Patents by Inventor Hyeon Cheol Gwon

Hyeon Cheol Gwon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for preventing or treating ischemic-reperfusion injury comprising bile acids
    Patent number: 11185553
    Abstract: The present invention relates to a composition for preventing, treating, or alleviating ischemia-reperfusion injury, containing bile acid. According to the present invention, bile acid increases intranuclear beta-catenin levels, interferes with the opening of a mitochondria permeable transition pore (mPTP), and has excellent effects, in ischemia-reperfusion injury animal models, of alleviating tissue injury and reducing the size of infarcts, thereby being usable in the prevention, treatment, or alleviation of ischemia-reperfusion injury.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: November 30, 2021
    Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Hyeon Cheol Gwon, Hyung Suk Jang
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ISCHEMIA-REPERFUSION INJURY, CONTAINING BILE ACID
    Publication number: 20190247406
    Abstract: The present invention relates to a composition for preventing, treating, or alleviating ischemia-reperfusion injury, containing bile acid. According to the present invention, bile acid increases intranuclear beta-catenin levels, interferes with the opening of a mitochondria permeable transition pore (mPTP), and has excellent effects, in ischemia-reperfusion injury animal models, of alleviating tissue injury and reducing the size of infarcts, thereby being usable in the prevention, treatment, or alleviation of ischemia-reperfusion injury.
    Type: Application
    Filed: October 31, 2017
    Publication date: August 15, 2019
    Inventors: Hyeon Cheol GWON, Hyung Suk JANG
  • COMPOSITION FOR PREVENTING, IMPROVING OR TREATING HAIR LOSS COMPRISING DEOXYCHOLIC ACID AS ACTIVE INGREDIENT
    Publication number: 20190125648
    Abstract: The present invention provides a composition comprising deoxycholic acid as an effective ingredient for preventing, alleviating, or treating hair loss. Based on deoxycholic acid that promotes proliferation and growth of follicular cells to ultimately exert a hair regrowth effect, the composition of the present invention can be applied as a hair loss preventing agent, a hair growth agent or a hair restorer.
    Type: Application
    Filed: August 11, 2016
    Publication date: May 2, 2019
    Inventors: Hyeon Cheol GWON, Dong Youn LEE, Hyung Suk JANG, Min Hee KIM
  • Pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives
    Patent number: 8518978
    Abstract: There is provided a pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives. The pharmaceutical composition includes a therapeutic effective amount of isoxazole derivatives represented by Formula 1 or pharmaceutically available salts thereof. The pharmaceutical composition may be useful to prevent and treat vascular restenosis since the pharmaceutical composition shows an anti-restenosis activity and accelerates the re-endothelization.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: August 27, 2013
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sun Gwan Hwang, Sang Rak Choi, Jeong Woo Cho, Sung Jin Bae, Tae Sung Koo, So Young Lee, Kyung Chul Cho, Hyeon Cheol Gwon
  • Pharmaceutical Composition For Preventintion And Treatment Of Restenosis Comprising Isoxazole Derivatives
    Publication number: 20110028506
    Abstract: There is provided a pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives. The pharmaceutical composition includes a therapeutic effective amount of isoxazole derivatives represented by Formula 1 or pharmaceutically available salts thereof. The pharmaceutical composition may be useful to prevent and treat vascular restenosis since the pharmaceutical composition shows an anti-restenosis activity and accelerates the re-endothelization.
    Type: Application
    Filed: June 30, 2008
    Publication date: February 3, 2011
    Inventors: Sun Gwan Hwang, Sang Rak Choi, Jeong Woo Cho, Sung Jin Bae, Tae Sung Koo, So Young Lee, Kyung Chul Cho, Hyeon Cheol Gwon